- Home
- SRZN vs PNNT Comparison
SRZN vs PNNT Comparison
Compare SRZN & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRZN | PNNT |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | 44 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.6M | 251.4M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | SRZN | PNNT |
|---|---|---|
| Price | $25.26 | $3.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $38.00 | $5.75 |
| AVG Volume (30 Days) | 249.8K | ★ 573.9K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 20.87% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $75.35 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.55 | $3.19 |
| 52 Week High | $35.00 | $7.53 |
Technical Indicators
Market Signals| Indicator | SRZN | PNNT |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 60.57 |
| Support Level | $20.26 | $3.61 |
| Resistance Level | $24.13 | $3.92 |
| Average True Range (ATR) | 1.89 | 0.11 |
| MACD | 0.25 | 0.05 |
| Stochastic Oscillator | 66.67 | 86.87 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.